Novel Formulation of Cannabinoid Analogues Treating DLBCL and MCL
Novel Formulation of Cannabinoid Analogues Treating DLBCL and MCL: Diffuse large B
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Novel Formulation of Cannabinoid Analogues Treating DLBCL and MCL: Diffuse large B
CBD Efficacy in Human DLBCL and MCL: Diffuse Large B-Cell Lymphoma
Non-Hodgkin Lymphoma (NHL), being the most common hematological malignancy, accounts for
Non-Hodgkin Lymphoma (NHL) is the most common hematological malignancy, with an
Effect of CBD Extract on Malignant Lymphoblastic Disease: Diffuse large B-cell
Non-Hodgkin Lymphoma (NHL), being the most common hematological malignancy, has long
Comparing novel cannabinoid analogues vs known cannabinoid analogues: Diffuse large B-cell
For authors and organisers
Find the right journal for your paper and submit your manuscript.